Calumet Specialty Prods Q2 EPS $(1.09) Misses $(0.34) Estimate, Sales $1.445B Beat $1.082B Estimate
Calumet Specialty Prods (NASDAQ:CLMT) reported quarterly losses of $(1.09) per share which missed the analyst consensus estimate of $(0.34) by 220.59 percent. This is a 35.88 percent increase over losses of $(1.70) per
Calumet lost more money per share than experts thought it would, which is bad news. But the company sold more stuff than expected, so there's something working even though the bottom line is tough right now.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.